SBSB
LLY icon

Sullivan, Bruyette, Speros & Blaney’s Eli Lilly LLY Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$422K Buy
2,258
+147
+7% +$28.8K 0.02% 200
2020
Q4 		$356K Buy
2,111
+191
+10% +$28.5K 0.02% 200
2020
Q3 		$284K Hold
1,920
– – 0.02% 210
2020
Q2 		$315K Sell
1,920
-1,237
-39% -$190K 0.02% 179
2020
Q1 		$438K Buy
3,157
+45
+1% +$6.18K 0.03% 134
2019
Q4 		$409K Hold
3,112
– – 0.02% 160
2019
Q3 		$348K Buy
3,112
+1
+0% +$111 0.02% 166
2019
Q2 		$345K Buy
3,111
+192
+7% +$22.6K 0.02% 164
2019
Q1 		$379K Buy
2,919
+153
+6% +$18.6K 0.02% 148
2018
Q4 		$320K Sell
2,766
-89
-3% -$9.94K 0.02% 147
2018
Q3 		$306K Sell
2,855
-113
-4% -$11.3K 0.03% 132
2018
Q2 		$253K Buy
2,968
+9
+0.3% +$739 0.02% 143
2018
Q1 		$229K Sell
2,959
-362
-11% -$29.1K 0.02% 150
2017
Q4 		$281K Sell
3,321
-182
-5% -$15.5K 0.03% 139
2017
Q3 		$300K Buy
+3,503
New +$287K 0.03% 128

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's LLY Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney increased its Eli Lilly (LLY) stake by 7% in Q1 2021, buying an estimated $28.8K and bringing the position to 2,258 shares worth $422K. The position accounts for 0.02% of the portfolio, ranked #200.

Sullivan, Bruyette, Speros & Blaney first reported a position in LLY in Q3 2017 and has held it in 15 quarters since. The position peaked at $438K in Q1 2020. 1,949 funds tracked by Wall St. Rank hold LLY as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 2,258 shares of Eli Lilly worth $422K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney bought 147 Eli Lilly shares in Q1 2021, an estimated $28.8K.
  • Eli Lilly made up 0.02% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #200 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Eli Lilly in Q3 2017 and has held it in 15 quarters since.
  • Sullivan, Bruyette, Speros & Blaney's Eli Lilly position peaked at $438K in Q1 2020.
  • 1,949 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.